A federal judge in Texas this week ruled that emails exchanged between Medtronic (NYSE:MDT) and Neurovision hashing out a settlement in their patent infringement dispute constitute a valid agreement, setting the stage for a hearing on whether the subsequent, unsigned contract is binding. Neurovision sued Medtronic in the the U.S. District Court for Eastern Texas in February 2016, […]
NeuroVision Medical Products Inc.
BSX loses $309M judgment in patent war with the family of Dr. Michel Mirowski | Medtech legal news for the week of September 29, 2014
Boston Scientific loses $309 million judgment in Mirowski patent war
September 24, 2014 by Brad Perriello
Judge upholds $30M infringement ruling against NuVasive, cancels trademark
NuVasive Forever Barred From Using NEUROVISION Trademark
Los Angeles, September 5, 2014 – A Los Angeles federal judge issued a permanent injunction earlier this week against NuVasive, Inc. (NUVA), forever barring the medical device manufacturer from using the trademark NEUROVISION to promote or sell medical devices in the United States.
Judge denies NuVasive in NeuroVision spat, cancels trademark
Federal Jury Awards $30 Million To Nerve Surveillance Device Manufacturer In Dispute Against NuVasive, Inc. (NUVA)
Los Angeles, April 3, 2014 – A federal jury awarded $30 million yesterday in a trademark infringement case brought by Neurovision Medical Products against NuVasive.
Medtech legal news for the week of Apr. 7, 2014
NuVasive loses 2nd, $30M trademark trial against NeuroVision
UPDATED April 7, 2014, with comment from NeuroVision
Teleflex affirms 2012 guidance | Wall Street Beat
Teleflex (NYSE:TFX) said yesterday that it expects its 2012 earnings to meet Wall Street’s expectations, but forecast softer profits for the coming year.
The Limerick, Pa.-based medical device company said its "preliminary financial goals" for 2013 are for sales growth of 11%-13% and adjusted EPS of $4.70-$4.90.
Appeals court reverses $60M NuVasive trademark loss
NuVasive Inc. (NSDQ:NUVA) won a big legal victory yesterday when a federal appeals court reversed a lower court’s $60 million decision in favor of NeuroVision Medical Products, rebuking the lower court judge in the process.
The decision means the case pitting the medical device companies against each other will be re-tried under a different district court judge.
Judges skeptical of $60M NeuroVision win over NuVasive | MassDevice.com Legal News
A trio of federal judges this week expressed skepticism over a $60 million trademark infringement win NeuroVision Medical Products logged against NuVasive Inc. (NSDQ:NUVA) in 2010.
NuVasive appealed the decision, arguing in March that the judge who handled the case "fundamentally misunderstood trademark law" and "exhibited hostility toward NuVasive’s counsel in front of the jury."
